Stomach Cancer Outcomes at KFSYSCC

Between 2013-2017, the five-year survival rate for stomach cancer at KFSYSCC was 48% vs 32% for other hospitals in Taiwan.

Basic Information and Stage Distribution of 1,797 Stomach Cancer Patients at KFSYSCC from 1990-2019

  
    


    
    
    


    
    
        
                
                Total
                1990-1994
                1995-1999
                2000-2004
                2005-2009
                2010-2014
                2015-2019
            

        
                n
                1,797
                56 (3%)
                181 (10%)
                434 (24%)
                377 (21%)
                436 (24%)
                313 (17%)
            

                Gender (%)
            

                Male
                1,027 (57%)
                30 (54%)
                112 (62%)
                258 (59%)
                205 (54%)
                250 (57%)
                172 (55%)
            

                Female
                770 (43%)
                26 (46%)
                69 (38%)
                176 (41%)
                172 (46%)
                186 (43%)
                141 (45%)
            

                Age
            

                Mean/Median
                59/60
                62/64
                59/61
                58/59
                58/58
                59/59
                60/61
            

                Range
                19-94
                27-86
                22-87
                21-90
                26-89
                19-92
                24-94
            

                Q1-Q3
                49-69
                56-72
                52-69
                47-69
                48-69
                51-69
                52-69
            

                Stage (%)
            

                0
                11 (1%)
                1 (2%)
                1 (1%)
                5 (1%)
                1 (0.3%)
                3 (1%)
                0 (0%)
            

                I
                409 (23%)
                8 (14%)
                32 (18%)
                96 (22%)
                100 (27%)
                92 (21%)
                81 (26%)
            

                II
                233 (13%)
                4 (7%)
                231 (3%)
                44 (10%)
                62 (16%)
                65 (15%)
                35 (11%)
            

                III
                392 (22%)
                5 (9%)
                241 (3%)
                63 (15%)
                65 (17%)
                140 (32%)
                95 (30%)
            

                IV
                588 (33%)
                21 (38%)
                553 (50%) 
                139 (32%)
                135 (36%)
                136 (31%)
                102 (33%)
            

                Unknown
                164 (9%)
                17 (30%)
                46 (25%)
                87 (20%)
                14 (4%)
                0 (0%)
                0 (0%)
            

    




  

	Total	1990-1994	1995-1999	2000-2004	2005-2009	2010-2014	2015-2019
n	1,797	56 (3%)	181 (10%)	434 (24%)	377 (21%)	436 (24%)	313 (17%)
Gender (%)
Male	1,027 (57%)	30 (54%)	112 (62%)	258 (59%)	205 (54%)	250 (57%)	172 (55%)
Female	770 (43%)	26 (46%)	69 (38%)	176 (41%)	172 (46%)	186 (43%)	141 (45%)
Age
Mean/Median	59/60	62/64	59/61	58/59	58/58	59/59	60/61
Range	19-94	27-86	22-87	21-90	26-89	19-92	24-94
Q1-Q3	49-69	56-72	52-69	47-69	48-69	51-69	52-69
Stage (%)
0	11 (1%)	1 (2%)	1 (1%)	5 (1%)	1 (0.3%)	3 (1%)	0 (0%)
I	409 (23%)	8 (14%)	32 (18%)	96 (22%)	100 (27%)	92 (21%)	81 (26%)
II	233 (13%)	4 (7%)	231 (3%)	44 (10%)	62 (16%)	65 (15%)	35 (11%)
III	392 (22%)	5 (9%)	241 (3%)	63 (15%)	65 (17%)	140 (32%)	95 (30%)
IV	588 (33%)	21 (38%)	553 (50%)	139 (32%)	135 (36%)	136 (31%)	102 (33%)
Unknown	164 (9%)	17 (30%)	46 (25%)	87 (20%)	14 (4%)	0 (0%)	0 (0%)

Based on KFSYSCC's cancer registry from 1990 to 2019, there were 1,797 analytic stomach cancer cases, with 1,027 males (57%) and 770 females (43%). The average and median ages were 59 and 60 years old, respectively; the youngest patient was 19 years old, and the oldest was 94 years old; the interquartile range (Q1-Q3) was 49-69. By stage, there were 11 stage 0 stomach cancer patients (1%), 409 stage I patients (23%), 233 stage II patients (13%), 392 stage III patients (22%), and 588 stage IV patients (33%). The table below presents the basic patient information and stage distribution, categorized by the year of diagnosis.

Line graph showing survival curves for stomach cancer patients, stratified by year of diagnosis, over a 10-year period, with decreasing probability of survival over time.

Survival Curves for 1,797 Stomach Cancer Patients (1990-2019), Stratified by Year of Diagnosis

From 1990 to 2019, the chart illustrates the five-year observed survival rates for 1,797 stomach cancer patients at KFSYSCC, stratified by the year of diagnosis. The graph shows the five-year survival rate for stomach cancer increased from 21% in 1990-1994 to 46% in 2015-2019, while the ten-year survival rate rose from 15% in 1990-1994 to 35% in 2010-2014.

Treatment Methods and Stages for 313 Stomach Cancer Patients at KFSYSCC (2015-2019)

  
    


    
    
    


    
    
        
            Treatment Type
            Total
            Stage I
            Stage II
            Stage III
            Stage IV
        

            Total
            313
            81
            35
            95
            102
        

            Surgical Treatment
            221 (71%)
            79 (98%)
            33 (94%)
            86 (91%)
            23 (23%)
        

            Radiation Therapy
            20 (6%)
            0 (0%)
            2 (6%)
            10 (11%)
            8 (8%)
        

            Chemotherapy
            193 (62%)
            10 (12%)
            25 (71%)
            74 (78%)
            84 (82%)
        

            Targeted Therapy
            19 (6%)
            0 (0%)
            1 (3%)
            3 (3%)
            15 (15%)
        

            Hormone Therapy
            1 (0.3%)
            0 (0%)
            1 (3%)
            0 (0%)
            0 (0%)
        

            Immunotherapy
            3 (1%)
            0 (0%)
            0 (0%)
            3 (3%)
            0 (0%)
        

            Palliative Care
            48 (15%)
            0 (0%)
            1 (3%)
            6 (6%)
            41 (40%)
        

            Bone Marrow/ Stem Cell Transplant
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
            0 (0%)
        

            No Record of Initial Treatment Reported
            3 (1%)
            2 (2%)
            0 (0%)
            0 (0%)
            1 (1%)
        





  

Treatment Type	Total	Stage I	Stage II	Stage III	Stage IV
Total	313	81	35	95	102
Surgical Treatment	221 (71%)	79 (98%)	33 (94%)	86 (91%)	23 (23%)
Radiation Therapy	20 (6%)	0 (0%)	2 (6%)	10 (11%)	8 (8%)
Chemotherapy	193 (62%)	10 (12%)	25 (71%)	74 (78%)	84 (82%)
Targeted Therapy	19 (6%)	0 (0%)	1 (3%)	3 (3%)	15 (15%)
Hormone Therapy	1 (0.3%)	0 (0%)	1 (3%)	0 (0%)	0 (0%)
Immunotherapy	3 (1%)	0 (0%)	0 (0%)	3 (3%)	0 (0%)
Palliative Care	48 (15%)	0 (0%)	1 (3%)	6 (6%)	41 (40%)
Bone Marrow/ Stem Cell Transplant	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)
No Record of Initial Treatment Reported	3 (1%)	2 (2%)	0 (0%)	0 (0%)	1 (1%)

Between 2015 and 2019, there were a total of 313 analytic stomach cancer cases, including 81 patients in stage I, 35 in stage II, 95 in stage III, and 102 in stage IV. In terms of treatment methods, 221 patients (71%) underwent surgical treatment, 20 (6%) received radiation therapy, 193 (62%) underwent chemotherapy, 19 (6%) received targeted therapy, 1 (0.3%) received hormone therapy, 3 (1%) received immunotherapy, 48 (15%) underwent palliative care, and 3 (1%) had no record of initial treatment reported.

A survival rate graph showing five-year survival rates of gastric cancer patients by stage, with stage I at 96%, stage II at 90%, stage III at 34%, and stage IV at 8%. The x-axis represents years after diagnosis, and the y-axis shows the probability of overall survival.

Five-Year Survival Rates of 313 Stomach Cancer Patients by Stage (2015-2019)

KFSYSCC’s 2015-2019 five-year observed survival rates for 313 stomach cancer patients, stratified by stage, are presented in the following chart. As shown in the graph, the five-year survival rate is 96% for stage 1, 90% for stage 2, 34% for stage 3, and 8% for stage 4.